| Product Information |
|
| Registration Number |
BR-1451
|
| Generic Name |
Pneumococcal Polysaccharide Conjugate Vaccine, 13-
Valent (Adsorbed)
|
| Brand Name |
Pneumocon-13
|
| Dosage Strength |
Each dose (0.5 mL) contains the capsular polysaccharide of the following Streptococcus pneumoniae serotypes:
Pneumococcal Polysaccharide Serotype 6B
Pneumococcal Polysaccharide Serotype 18C
Pneumococcal Polysaccharide Serotype 4, 23F
Pneumococcal Polysaccharide Serotype 7F
Pneumococcal Polysaccharide Serotype 14, 19F
Pneumococcal Polysaccharide Serotype 1, 19A
6.0 με 3.25 μg
3.0 με
2.85 με
- 2.75 με
2.6 με
Pneumococcal Polysaccharide Serotype 3, 5, 6A, 9V Conjugated to Tetanus Toxoid carrier protein
2.5 με 41-150 με
|
| Dosage Form |
Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL in 1 mL pre-filled glass syringe with grey
bromobutyl plunger stopper and polystyrene plunger rod with 27G stainless steel needle (Box of 1's).
|
| Pharmacologic Category |
-
|
| Manufacturer |
Yuxi Walvax Biotechnology Co., Ltd.
|
| Country of Origin |
China
|
| Trader |
N/A
|
| Importer |
2 World Traders Inc.
|
| Distributor |
2 World Traders Inc.
|
| Application Type |
Monitored Release (MR) [Reapplication]
|
| Issuance Date |
03 November 2023
|
| Expiry Date |
03 November 2028
|